The therapeutic potential of Wild Bitter Melon to ameliorate muscle atrophy in a murine model

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 31

فایل این مقاله در 14 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AJP-14-3_010

تاریخ نمایه سازی: 9 اردیبهشت 1403

چکیده مقاله:

Objective: Muscle atrophy due to immobility is a common complication of many diseases and a consequence of therapeutic processes. Immobility and inactivity have been shown to be associated with increased inflammation. The aim of this study was to investigate the therapeutic potential of Wild Bitter Melon (WBM) (Momordica charantia Linn) on muscle atrophy due to immobility in a mouse model.Materials and Methods: This study was performed in two phases of atrophy and recovery on male BALB/c mice which were divided into ۳ groups: control, immobilized, and experimental. The treatment period with WBM at a dose of ۴۰۰ mg/kg daily by gavage was ۱۷ days, including ۷ days of being immobilized and ۱۰ days of recovery. At the end of each phase, half of the mice from each group were examined regarding the four limb grip strength, and then histological and biochemical analyses were done.Results: The tissue level of malondialdehyde (MDA) oxidative stress index in the atrophy phase in the atrophy group (۵.۴۵۶۷±۰.۵۲۲) nmol/g compared to the control group (۳.۴۵۵±۰.۰۶۵) nmol significantly (p ۰.۰۰۱) <) increased. Also, the tissue level of MDA in the WBM group (۳.۸۷±۰.۰۳۵) showed a significant decrease compared to the atrophy group (p<۰.۰۱). The strength percentage of four limbs in the mice of the treatment group (-۲۳.۴۶±۲.۴۵) was significantly higher than that of the atrophy group (-۳۰.۶۰±۳.۱۵) at the end of the atrophy phase.Conclusion: The results suggest that the use of WBM reduces the degree of inflammation, oxidative stress and muscle damage, as well as muscle atrophy, which may improve the muscle atrophy in mice.

نویسندگان

Sima Seifi

Metabolic Disorders Research Center, Department of Biochemistry and Biophysics, Golestan University of Medical Sciences Gorgan, Golestan, Iran

Seyedeh Elnaz Nazari

Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran

Amir Avan

Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran

Nima Khalili-tanha

Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran

Fatemeh Babaei

Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran

Saman Soleimanpour

Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran

Fereshteh Asgharzadeh

Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran

Mousa-al-reza Hajzadeh

Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Majid Khazaei

Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Abdoljalal Marjani

Metabolic Disorders Research Center, Department of Biochemistry and Biophysics, Golestan University of Medical Sciences Gorgan, Golestan, Iran